Sep 28 2010
Medical device company, St. Jude Medical will showcase its new Optical Coherence Tomography (OCT) solution at the 22nd Transcatheter Cardiovascular Therapeutics annual meeting, in Washington, D.C.
C7-XR OCT Intravascular Imaging System
The C7-XR OCT Intravascular Imaging System complements St. Jude Medical’s PressureWire Fractional Flow Reserve (FFR) measurement technology platform, providing new standard for complete intravascular lesion diagnosis.
The C7-XR OCT System helps physicians in treating cardiovascular disease. It utilizes near-infrared light to generate high-resolution images. These images enable physicians to visualize and calculate vital vessel characteristics. The C7-XR OCT platform adds anatomical information to the physiological data offered by FFR measurements. The FFR precisely recognizes stent and lesions. The OCT-guided treatment is significant for stent placement examination, as it accurately indicates the position of the stent against the artery wall.
The C7-XR System also offers physicians with post-stenting data by analyzing the stent’s deployment and position. The OCT technology offers complete information related to the vessel’s inner lining. In addition, the technology provides information regarding the reappearance of the narrowing of blood vessels.